{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Northridge",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "87476",
      "recalling_firm": "Medtronic Inc.",
      "address_1": "18000 Devonshire St",
      "address_2": "N/A",
      "postal_code": "91325-1219",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Worldwide distribution.",
      "recall_number": "Z-1614-2021",
      "product_description": "Medtronic REF: MMT-7020D3 Guardian Sensor (3)  for the following packaging:     GS3 1 PK OUS3/ GTIN:\t00643169704121  GS3 1PK 9L OUS3/ GTIN: 00763000318895  Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes.    *Product not distributed within US.",
      "product_quantity": "13,014 units",
      "reason_for_recall": "Use of the continuous glucose monitoring system while actively taking   hydroxyurea, an anti-neoplastic drug  could result in inaccurate elevated sensor glucose readings.",
      "recall_initiation_date": "20210226",
      "center_classification_date": "20210517",
      "report_date": "20210526",
      "code_info": "All Lot numbers within active shelf life"
    }
  ]
}